把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注,缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存;每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR,A 股链接巨潮原始 PDF,港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性,不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查;超出容差的记录保留原值并标记警告, 不会为了让公式“对上”而修改公司披露。
| 2026-03-31 |
| 3/3 |
| $105.4M |
| -$11.3M |
| $2.24M |
| 90.7% |
| -8.6% |
| 91 |
| 尚无授权文本 |
| ARTV Artiva Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$21.19M | — | — | 27 | 尚无授权文本 |
| ATRA Atara Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $516,000 | -$4.15M | — | — | -652.9% | 109 | 尚无授权文本 |
| BOLT Bolt Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $26,000 | -$7.24M | — | — | -29234.6% | 65 | 尚无授权文本 |
| BRNS Barinthus Biotherapeutics plc. | 2026-03-31 | 3/3 | — | -$5.53M | -$3.37M | — | — | 74 | 尚无授权文本 |
| BTMD biote Corp. | 2026-03-31 | 3/3 | $44.94M | $2.28M | $3.54M | — | 7.0% | 83 | 尚无授权文本 |
| CLDI Calidi Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.11M | — | — | — | 119 | 尚无授权文本 |
| EDSA Edesa Biotech, Inc. | 2026-03-31 | 3/3 | — | -$4.22M | — | — | — | 87 | 尚无授权文本 |
| FBIO Fortress Biotech, Inc. | 2026-03-31 | 3/3 | $16.04M | $110.37M | — | 61.2% | -48.3% | 104 | 尚无授权文本 |
| FBIOP Fortress Biotech, Inc. | 2026-03-31 | 3/3 | $16.04M | $110.37M | — | 61.2% | -48.3% | 104 | 尚无授权文本 |
| IOVA IOVANCE BIOTHERAPEUTICS, INC. | 2026-03-31 | 3/3 | $71.43M | -$79.05M | -$78.68M | 40.5% | -113.5% | 119 | 尚无授权文本 |
| KRYS Krystal Biotech, Inc. | 2026-03-31 | 3/3 | $116.36M | $55.93M | $73.23M | — | 46.1% | 103 | 尚无授权文本 |
| LAB STANDARD BIOTOOLS INC. | 2026-03-31 | 3/3 | $21.15M | $127.07M | -$47.17M | 53.5% | -59.1% | 108 | 尚无授权文本 |
| LABT Lakewood-Amedex Biotherapeutics Inc. | 2026-03-31 | 3/3 | — | -$923,291 | — | — | — | 4 | 尚无授权文本 |
| MAIA MAIA Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$6.37M | — | — | — | 124 | 尚无授权文本 |
| MBRX Moleculin Biotech, Inc. | 2026-03-31 | 3/3 | $0 | -$12.85M | — | — | — | 287 | 尚无授权文本 |
| NAUT Nautilus Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$14.7M | -$13.61M | — | — | 65 | 尚无授权文本 |
| ONCY ONCOLYTICS BIOTECH INC | 2026-03-31 | 3/3 | — | -$9.24M | -$7.3M | — | — | 229 | 尚无授权文本 |
| PBYI PUMA BIOTECHNOLOGY, INC. | 2026-03-31 | 3/3 | $44.81M | -$3.75M | $15.42M | 76.7% | -8.5% | 83 | 尚无授权文本 |
| PDSB PDS Biotechnology Corp | 2026-03-31 | 3/3 | — | -$7.35M | — | — | — | 204 | 尚无授权文本 |
| PLX Protalix BioTherapeutics, Inc. | 2026-03-31 | 3/3 | $33.75M | $18.32M | $21.26M | 87.8% | 62.7% | 101 | 尚无授权文本 |
| SABS SAB Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$18.87M | -$15.25M | — | — | 101 | 尚无授权文本 |
| SANA Sana Biotechnology, Inc. | 2026-03-31 | 3/3 | — | -$47.21M | -$37.67M | — | — | 87 | 尚无授权文本 |
| TRAX First Tracks Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$50.48M | -$32.58M | — | — | 5 | 尚无授权文本 |
| VIR Vir Biotechnology, Inc. | 2026-03-31 | 3/3 | -$29,000 | -$125.7M | -$132.78M | — | 456172.4% | 108 | 尚无授权文本 |
| XBIT XBiotech Inc. | 2026-03-31 | 3/3 | — | -$5.51M | -$8.97M | — | — | 39 | 尚无授权文本 |
| BNR Burning Rock Biotech Ltd | 2025-12-31 | 3/3 | $539.57M | -$55.35M | -$4.82M | 74.7% | -10.2% | 62 | 尚无授权文本 |
| CLGN CollPlant Biotechnologies Ltd | 2025-12-31 | 3/3 | $2.37M | -$11.49M | -$9.45M | 64.8% | -484.3% | 111 | 尚无授权文本 |
| LEGN Legend Biotech Corp | 2025-12-31 | 2/3 | — | -$296.8M | — | — | — | 190 | 尚无授权文本 |
| LKFT Lakefront Biotherapeutics NV | 2025-12-31 | 2/3 | — | $320.88M | — | — | — | 215 | 尚无授权文本 |
| MENS Jyong Biotech Ltd. | 2025-12-31 | 3/3 | — | -$4.67M | — | — | — | 4 | 尚无授权文本 |
| NBTX Nanobiotix S.A. | 2025-12-31 | 2/3 | — | -$23.96M | — | — | — | 229 | 尚无授权文本 |
| NNNN Anbio Biotechnology | 2025-12-31 | 3/3 | $8.65M | $6.4M | — | 87.2% | 66.7% | 9 | 尚无授权文本 |
| PPBT PURPLE BIOTECH LTD. | 2025-12-31 | 3/3 | — | -$26.49M | — | — | — | 175 | 尚无授权文本 |
| ZYBT Zhengye Biotechnology Holding Ltd | 2025-12-31 | 3/3 | $116.36M | -$69.78M | $1.77M | 20.5% | -60.6% | 13 | 尚无授权文本 |
| HKPD Cellyan Biotechnology Co., Ltd | 2025-09-30 | 2/3 | — | $153,735 | — | — | — | 13 | 尚无授权文本 |
| TRIB TRINITY BIOTECH PLC | 2024-12-31 | 2/3 | — | -$31.22M | — | — | — | 143 | 尚无授权文本 |
| BIOT INSTINCT BIO TECHNICAL CO HOLDINGS INC. | — | 0/3 | — | — | — | — | — | 3 | 尚无授权文本 |